Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;36(1):e22942.
doi: 10.1002/jbt.22942. Epub 2021 Nov 2.

Imbalanced GSH/ROS and sequential cell death

Affiliations
Review

Imbalanced GSH/ROS and sequential cell death

Ting Liu et al. J Biochem Mol Toxicol. 2022 Jan.

Abstract

Reactive oxygen species (ROS) are produced in cells during metabolic processes. Excessive intracellular ROS may react with large biomolecules, such as DNA, RNA, proteins, and small biomolecules, that is, glutathione (GSH) and unsaturated fatty acids. GSH has physiological functions, including free radical scavenging, anti-oxidation, and electrophile elimination. The disruption of ROS/GSH balance results in the deleterious oxidation and chemical modification of biomacromolecules, which eventually leads to cell-cycle arrest and proliferation inhibition, and even induces cell death. Imbalanced ROS/GSH may result from a direct increase of ROS, consumption of GSH, intracellular oxidoreductase interference, or thioredoxin activity reduction. Some chemicals including arsenic trioxide (ATO), pyrogallol (PG), and carbobenzoxy-Leu-Leu-leucinal (MG132) could also disrupt the balance of GSH and ROS. This article reviews the occurrence and consequences of the imbalance between GSH and ROS and introduces factors responsible for the disruption of cellular ROS and GSH balance, resulting in cell death. "GSH" and "ROS" were used as keywords to search the relevant literaturess.

Keywords: GSH; ROS; apoptosis; redox balance; stress signaling pathways.

PubMed Disclaimer

References

REFERENCES

    1. W. H. Park, B. R. You, Int. J. Oncol. 2016, 48, 813.
    1. C. Park, J. W. Jeong, M. H. Han, H. Lee, G. Y. Kim, S. Jin, J. H. Park, H. J. Kwon, B. W. Kim, Y. H. Choi, Anim. Cells Syst. 2021, 25, 119.
    1. C. H. Tsai, P. W. Hsieh, Y. C. Lee, C. H. Wang, W. C. Chiu, C. W. Lu, Y. Y. Wang, S. C. Hu, T. L. Cheng, S. F. Yuan, Life Sci. 2017, 172, 19.
    1. S. M. Lee, Y. S. Lee, J. H. Choi, S. G. Park, I. W. Choi, Y. D. Joo, W. S. Lee, J. N. Lee, I. Choi, S. K. Seo, Immunol. Lett. 2010, 132, 53.
    1. S. K. Jain, D. Micinski, Biochem. Biophys. Res. Commun. 2013, 437, 7.

LinkOut - more resources